RT Journal Article
SR Electronic
T1 Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 269
DO 10.1186/s40425-019-0723-9
VO 7
IS 1
A1 Rajan, Arun
A1 Heery, Christopher R.
A1 Thomas, Anish
A1 Mammen, Andrew L.
A1 Perry, Susan
A1 O’Sullivan Coyne, Geraldine
A1 Guha, Udayan
A1 Berman, Arlene
A1 Szabo, Eva
A1 Madan, Ravi A.
A1 Ballester, Leomar Y.
A1 Pittaluga, Stefania
A1 Donahue, Renee N.
A1 Tsai, Yo-Ting
A1 Lepone, Lauren M.
A1 Chin, Kevin
A1 Ginty, Fiona
A1 Sood, Anup
A1 Hewitt, Stephen M.
A1 Schlom, Jeffrey
A1 Hassan, Raffit
A1 Gulley, James L.
YR 2019
UL http://jitc.bmj.com/content/7/1/269.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.